Business
Microbix Announces Closing of Second Tranche of Private Placement of $359,000
/NOT INTENDED FOR DISSEMINATION IN THE UNITED STATES OR DISTRIBUTION TO UNITED STATES NEWSWIR...

About this update from Microbix Biosystems Inc.
[{"type":"text","content":"\n\n\n\n\n\n/NOT INTENDED FOR DISSEMINATION IN THE UNITED STATES OR DISTRIBUTION TO\n UNITED STATES NEWSWIRE SERVICES /\n\n\nTORONTO, Aug. 4, 2011 /CNW/ - Microbix Biosystems Inc. (TSX:MBX)\n (\"Microbix\" or the \"Company\"), a biotechnology company focused on\n virology and biological technologies, announces the closing on August\n 3, 2011 of the second tranche of a private placement financing\n resulting in the issuance of a further 1,026,452 Units at a price of\n $0.35 per Unit for gross proceeds of $359,258. Each Unit consists of\n one common share of Microbix and one-half common share purchase\n warrant. Each whole Warrant entitles the holder to purchase one\n additional common share at an exercise price of $0.45 for 24 months.\n\n\nA director and officer of the Company participated in the financing by\n purchasing 142,857 Units. The financing was non-brokered. The Company\n intends to use the proceeds of the private placement for general\n corporate purposes.\n\n\nThe securities issued in the private placement are subject to hold\n period of four months and one day from the date of issue. The private\n placement remains subject to the final approval of the Toronto Stock\n Exchange.\n\n\nThe securities described herein have not been and will not be registered\n under the United States Securities Act of 1933, as amended, and may not\n be offered or sold in the United States or to a U.S. Person absent an\n exemption from the registration requirements.\n\n\nMicrobix Biosystems Inc. specializes in the development of biological\n technologies and commercializing them through global partners. The\n Company has intellectual property in large market biotherapeutic drugs,\n vaccine technologies and animal reproduction technologies. Established\n in 1988, Microbix is headquartered in Toronto. This press release\n contains forward-looking statements, which are subject to risks and\n uncertainties that could cause actual results to differ materially from\n those set forth in the forward-looking. These forward-looking\n statements represent the Company's judgment as of the date of this\n press release. The Company disclaims any intent or obligation to update\n these forward-looking statements.\n\n\nThe Toronto Stock Exchange does not accept responsibility for the\n adequacy or accuracy of this release.\n\n\n","length":2526,"tagName":"d...